Form 4: Director Colleen Reitan Receives Myriad Genetics Equity

Director Colleen F. Reitan was granted 59,701 restricted stock units by Myriad Genetics, Inc. as part of the 2026 equity incentive plan.

Summary

• Director Colleen F. Reitan acquired 59,701 restricted stock units (RSUs) on June 4, 2026.
• The grant was issued under the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock.
• The total beneficial ownership for the director following this transaction is 152,030 shares.
• The RSUs vest on the earlier of the first anniversary of the grant or the date of the next annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential dilution from future incentive plan issuances.

Future Outlook

The RSUs are subject to vesting conditions based on the passage of time or the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment in the biotechnology sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded companies in the healthcare and diagnostics industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 59,701 RSUs on the earlier of the first anniversary of the grant or the next annual meeting of stockholders.

Key Dates

Keywords

Myriad Genetics, MYGN, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation